scispace - formally typeset
M

Maithé Tauber

Researcher at Boston Children's Hospital

Publications -  183
Citations -  8106

Maithé Tauber is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 43, co-authored 167 publications receiving 6913 citations. Previous affiliations of Maithé Tauber include Paul Sabatier University & French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations

TL;DR: In addition to FTO and MC4R, genome-wide association data from 1,380 Europeans with early-onset and morbid adult obesity and 1,416 age-matched normal-weight controls detected significant association of obesity with three new risk loci in NPC1, near MAF and near PTER.
Journal ArticleDOI

Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human

TL;DR: This study demonstrates that the lipid sensor GPR120 has a key role in sensing dietary fat and, therefore, in the control of energy balance in both humans and rodents.
Journal ArticleDOI

A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk

TL;DR: The data suggest a possible link between circadian rhythm regulation and glucose homeostasis through the melatonin signaling pathway and show MT2 expression in human pancreatic islets and beta cells.
Journal ArticleDOI

Recommendations for the Diagnosis and Management of Prader-Willi Syndrome

TL;DR: The diagnosis and management of this complex disorder requires a multidisciplinary approach with particular emphasis on the importance of early diagnosis using accredited genetic testing, use and monitoring of GH therapy from early childhood, control of the food environment and regular exercise.
Journal ArticleDOI

Growth hormone research society workshop summary: Consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome

TL;DR: Following a multidisciplinary evaluation, preferably by experts, rhGH treatment should be considered for patients with genetically confirmed PWS in conjunction with dietary, environmental, and lifestyle interventions.